The International Society for Pharmaceutical Engineering (ISPE) is a nonprofit association serving its members by leading scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle.
ISPE: In One Word
As the pharmaceutical and biotech industry forges new paths and breaks new grounds, ISPE is here to support you on your journey to Shape the Future of Pharma™
ISPE's Strategic Vision
We are dedicated to enhancing the quality of human life through the power of our community of Life Sciences professionals by sharing knowledge and igniting innovation.
Who We Are
In a world where the pursuit of excellence knows no boundaries, ISPE is shaping the future of the pharmaceutical industry. We are committed to the advancement of the educational and technical efficiency of our members.
ISPE was founded in 1980 by a handful of people who believed the pharmaceutical industry needed an organization that would deal with practical applications of science and technology for technical professionals. The much-needed forum provided by ISPE began with a membership of engineers in North America. We recognize and thank each of our Founding Members for their forethought and inspirational ideas, which led to ISPE’s establishment and have helped continued to impact who we are today.
Today, our membership base has expanded far beyond engineering to include a broad representation of more than 25,000 pharmaceutical professionals, representing 120 countries. We also have ISPE Communities of Practice (CoPs), which serve as technical engines uniting professionals worldwide to generate meaningful content in our gold standard documents, training programs, and conference programs. ISPE CoPs cover 20 unique technical areas in the pharmaceutical industry, including GAMP® which celebrated its 30th anniversary in 2021. Professional communities include Affiliates/Chapters, Women in Pharma®, and Emerging Leaders. ISPE’s networking platform ISPE Engage continues to facilitate an open forum for all members and each community of practice to virtually connect and collaborate.
On matters of regulation, our focus is on those requirements that impact — or will impact — the licensing of facilities, manufacturing processes and operations, and the sustainability of the supply chain over the product lifecycle. We are proud to have more than 2,600+ ISPE members from regulatory authorities representing 73 countries. We provide a neutral environment where members and experts can engage in open dialogue on issues that will ultimately benefit patients around the world.
Guiding Principals
Act with Integrity
We hold ourselves to the highest standards of honesty, transparency, and ethical conduct. In every interaction with our members, our partners, and each other, we do what is right, even when it isn't easy. Trust is the foundation of our community, and we earn it through our actions every day.
Embrace Collaboration
We believe the best outcomes are achieved together. As a global community of life sciences professionals, we break down silos, welcome diverse perspectives, and work across disciplines and borders to solve shared challenges. When we collaborate openly, we multiply our impact.
Lead with Curiosity
We ask bold questions, challenge assumptions, and seek to understand before we act. Curiosity drives us to explore new approaches, stay ahead of an evolving industry, and continuously grow as professionals and as an organization. It is the spark behind every innovation that shapes the future of pharma.
Our Members
All scientific and technical areas of the pharmaceutical manufacturing industry are represented among the ISPE membership. Engineers, microbiologists, chemists, QA/QC, production, process development, pharmacists, regulatory and training personnel, academia, suppliers, and other professionals contribute their expertise to the industry through their participation in ISPE activities.
Our Leaders
ISPE is led by the International Board of Directors. Vivianne Arencibia is the Association's Chair for 2025-2026.
Our Staff
ISPE is supported by a global staff of association professionals and advisers under the leadership of President & CEO, Mike Martin.